Novartis to Buy Multiple Sclerosis Drug From Glaxo
The experimental drug ofatumumab would bolster the Swiss pharmaceutical company’s portfolio of multiple sclerosis treatments.
Continue Reading http://www.nytimes.comThe experimental drug ofatumumab would bolster the Swiss pharmaceutical company’s portfolio of multiple sclerosis treatments.
Continue Reading http://www.nytimes.com
Join the Discussion